Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Network Meta-Analysis of Glucagon-Like Peptide-1 Receptor Agonists, Metformin, and Inositol for Enhancing Metabolic and Anthropometric Outcomes in Women with Polycystic Ovary Syndrome

  • By

  • Asad Omarion

  • Yaman Ayasa

  • Zainab Omarion

  • Batoul Jayouse

  • Hazem Ayesh

  • July 3, 2026

Share

Original Source(s)

Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis

  • by Asad Omarion, Yaman Ayasa, Zainab Omarion, Batoul Jayouse, Hazem Ayesh

  • July 3, 2026

Related Content

Identification of predictors of the ovarian response to clomiphene citrate in infertile women with polycystic ovary syndrome: A post-hoc analysis of a randomized controlled trial

Integrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications

Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes